BioSpace News Archive

Cardiovascular disease

Merck’s Winrevair Cuts Morbidity, Mortality Risk by Over 75% in Phase III PAH Study

Merck continues to build the case for the pulmonary arterial hypertension drug that won FDA approval in 2024.

April 1, 2025

·

2 min read

·

Tristan Manalac

Robert F Kennedy Jr speaking at the White House

Government

Calls To End Kennedy’s Leadership Follow Marks’ Abrupt Exit

Analysts at financial firm Cantor Fitzgerald are urging President Donald Trump to rethink his appointment of Robert F. Kennedy Jr. as Secretary of Health and Human Services.

April 1, 2025

·

2 min read

·

Tristan Manalac

Layoffs

Carisma Lays Off Most of Staff, Eyes Sale of Assets and Company

Cell therapy and oncology–focused Carisma Therapeutics started layoffs late last year. Now the company plans to wind down fully.

April 1, 2025

·

1 min read

·

Dan Samorodnitsky

Employees Walking In And Out Of The Door, Some Were Leaving Their Job And Some Were Being Hired At The Same Time. Full Length, Isolated On Solid Color Background. Vector, Illustration, Flat Design, Character.

Layoffs

Organon Lets Go of 93 Employees in New Jersey in Continuing Workforce Cuts

Organon’s workforce cuts come several months after the company’s loss of exclusivity to its second-largest product, Atozet.

April 1, 2025

·

2 min read

·

Angela Gabriel

Hand holding pencil erasing an employee. Dismissal or bankrumptcy concept. Vector illustration.

Layoffs

Tenaya Slashes a Third of Workforce To Fund Development of Cardio Gene Therapies

The layoffs will take place throughout 2025 and will mostly affect Tenaya’s research and manufacturing operations. The company is continuing to test its hypertrophic cardiomyopathy gene therapy.

April 1, 2025

·

2 min read

·

Tristan Manalac

Concept of money prize. Vector illustration. Halftone hand holds bouquet of money flowers. Gift prize, donation, earnings, bonus or cashback concept. Retro poster or banner. Creative trend collage.

Funding

AIRNA Hits $155M Series B Haul To Advance RNA Editor for Rare Genetic Disease

AIRNA’s lead candidate AIR-001 works by correcting the most common pathologic mutation driving the rare disease alpha-1 antitrypsin deficiency.

April 1, 2025

·

2 min read

·

Tristan Manalac

FDA signage at its headquarters in Maryland

FDA

FDA Layoffs Continue as Former Commissioner Robert Califf Speaks Out

The latest cuts, which are part of a larger reduction of 10,000 at the Department of Health and Human Services, were reportedly underway Tuesday, with CDER Office of New Drugs Director Peter Stein added to the list of casualties.

April 1, 2025

·

2 min read

·

Heather McKenzie